Jasper Therapeutics
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and gene therapies. The company s novel engineered hematopoietic stem cells (eHSCs) platform aims to overcome the limitations of transplant grafts while also unlocking the potential of stem cells, potentially increasing the number of patients who could benefit from allogeneic and autologous gene-edited hematopoietic stem cell therapy. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Domain
jaspertherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$30.0M
Founded
2017
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Jasper Therapeutics use?+
Jasper Therapeutics uses 18 technologies including cdnjs, Font Awesome, Modernizr.
What industry is Jasper Therapeutics in?+
Jasper Therapeutics operates in the Biotechnology industry.
Where is Jasper Therapeutics based?+
Jasper Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026